serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.490 Epilepsy .
C10.228.140.490.375 Epilepsy, Generalized .
C10.228.140.490.375.130 Epilepsies, Myoclonic .
C10.228.140.490.375.130.650 Myoclonic Epilepsies, Progressive .
C10.228.140.490.375.130.650.500 Lafora Disease .
C10.228.140.490.493 Epileptic Syndromes .
C10.228.140.490.493.063 Epilepsies, Myoclonic .
C10.228.140.490.493.063.650 Myoclonic Epilepsies, Progressive .
C10.228.140.490.493.063.650.500 Lafora Disease .
C10.574 Neurodegenerative Diseases .
C10.574.500 Heredodegenerative Disorders, Nervous System .
C10.574.500.529 Lafora Disease .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.400 Heredodegenerative Disorders, Nervous System .
C16.320.400.480 Lafora Disease .
D03 Heterocyclic Compounds .
D03.132 Alkaloids .
D03.132.206 Cinchona Alkaloids .
D03.132.206.719 Quinine .
D03.605 Heterocyclic Compounds, Bridged-Ring .
D03.605.687 Quinuclidines .
D03.605.687.762 Quinine .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.810 Quinolines .
D03.633.100.810.762 Quinine .
I01 Social Sciences .
I01.615 Internationality .
I01.615.500 International Cooperation .
SH1 Health Sciences, Technology and Innovation Management .
SH1.010 Policies and Cooperation in Science, Technology and Innovation .
SH1.010.020 International Cooperation .
SP4 Environmental Health .
SP4.011 Science .
SP4.011.127 Social Sciences .
SP4.011.127.423 Technical Cooperation .
SP4.011.127.423.734 Joint Ventures, Non-Medical .
SP4.011.127.423.734.010 International Cooperation .
SP4.011.127.423.739 Economic Cooperation .
SP4.011.127.423.739.025 International Cooperation .
SP4.011.127.433 Legislation, Environmental .
SP4.011.127.433.819 Joint Ventures, Non-Medical .
SP4.011.127.433.819.090 International Cooperation .
SP4.011.127.433.869 International Cooperation .
SP9 Health Law .
SP9.050 International Law .
SP9.050.030 International Cooperation .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
International Cooperation .
Treaties .
Aid, Foreign .
Cooperation, International .
Treaty .
Foreign Aid .
Pact 5670 .
Bilateral Agreements .
Bilateral Pacts .
Regional Agreements .
Regional Pacts .
International Agreements .
International Conventions .
International Pacts .
International Treaties .
Associação das Nações do Sudeste Asiático (ASEAN) .
ANZCERTA .
OECS 5670 .
Andean Pact .
European Free Trade Association .
American Free Trade Association .
LAFTA .
CEPANZO .
INPPAZ .
ACS 5670 .
Association of Caribbean States .
LAIA 5670 .
Latin American Integration Association .
ASEAN .
Association of South-East Asian Nations .
Association of Southeast Asian Nations .
Andean Community .
Organisation of Eastern Caribbean States .
EFTA 5670 .
SADC 5670 .
Southern African Development Community .
Globalization .
NAFTA .
North America Free Trade Agreement .
Caribbean Community .
Caribbean Community and Common Market .
CARICOM .
Economic Blocs .
Commercial Blocks .
Commercial Blocs .
Economic Blocks .
CACM 5670 .
Central American Common Market .
BSEC 5670 .
Black Sea Economic Cooperation .
APEC 5670 .
Asia-Pacific Economic Cooperation .
Asian Pacific Economic Cooperation .
Australia New Zealand Closer Economic Relations Trade Agreement .
AZCERTA .
FTAA 5670 .
Free Trade Area of the Americas .
Enterprise for the Americas Initiative .
The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest. .
1.00
162841300
 
Lafora Disease .
Epilepsy Progressive Myoclonic 2 .
Epilepsy, Progressive Myoclonic 2A .
Lafora Body Disease .
Lafora Body Disease, Late Onset .
Lafora Body Disorder .
Lafora Progressive Myoclonic Epilepsy .
Lafora Progressive Myoclonus Epilepsy .
Lafora Type Progressive Myoclonic Epilepsy .
Lafora-Body Disease, Late Onset .
Late Onset Lafora Body Disease .
Myoclonic Epilepsy of Lafora .
Progressive Myoclonic Epilepsy Type 2 .
Progressive Myoclonic Epilepsy, Lafora .
Progressive Myoclonus Epilepsy, Lafora Type .
Lafora Myoclonic Epilepsy .
Epilepsy, Progressive Myoclonic, Lafora .
Progressive Myoclonic Epilepsy, Lafora Type .
A form of stimulus sensitive MYOCLONIC EPILEPSY inherited as an autosomal recessive condition. The most common presenting feature is a single seizure in the second decade of life. This is followed by progressive myoclonus, myoclonic seizures, tonic-clonic seizures, focal occipital seizures, intellectual decline, and severe motor and coordination impairments. Most affected individuals do not live past the age of 25 years. Concentric amyloid (Lafora) bodies are found in neurons, liver, skin, bone, and muscle (From Menkes, Textbook of Childhood Neurology, 5th ed, pp111-110). .
0.55
7239
 
Quinine .
Biquinate .
Legatrim .
Myoquin .
Quinamm .
Quinbisan .
Quinbisul .
Quindan .
Quinimax .
Quinine Bisulfate .
Quinine Hydrochloride .
Quinine Lafran .
Quinine Sulfate .
Quinine Sulphate .
Quinine-Odan .
Quinoctal .
Quinson .
Quinsul .
Strema .
Surquina .
Bisulfate, Quinine .
Hydrochloride, Quinine .
Sulfate, Quinine .
Sulphate, Quinine .
An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. .
0.49
695399